AMSilk founder receives DECHEMA Award
AMSilk’s co-founder Prof. Dr. Thomas Scheibel receives the 2013 DECHEMA award of the Max-Buchner-Research-Foundation for his work on spider silk. The DECHEMA award includes price money of 20.000 Euro.
Prof. Scheibel is one the world’s leading scientists studying how spider silk works and how it can be manufactured by biotechnological processes. While he is focused on basic research, the results of his work laid the foundation for AMSilk, a German company which focuses on turning state-of-art research results into real life products, such as high performance fibers, wound care products and medical devices. One of his key discoveries is that silicone implants coated with recombinant spider silk protein are better accepted by the body and thereby undesirable side effects are reduced.
Prof. Scheibel is full professor at the chair of biomaterials at the University of Bayreuth in Germany.
Other news from the department science
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Spectro Scientific acquired by AMETEK
Hach Lange announces name change
Trust in AI but not blindly - Artificial intelligence is sometimes met with scepticism but it has earned our trust
Nanotubes: cellular membranes on supply - Osmotic forces play a role in nanotube formation in cells
Microorganisms build the best fuel efficient hydrogen cells
DataApex audited for ISO 9001 standards
Graphene plasmons go ballistic - Graphene combined with the insulting power of boron nitride enables light control in tiny circuits with dramatically reduced energy loss
Artificial intelligence could improve therapy for lymphoma
SALVE Project Enters Second Phase - Successful evaluation phase prompts University of Ulm and Carl Zeiss to continue with their joint venture to develop a high-performance transmission electron microscope
Fluorescence spectroscopy using a smartphone